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Summary Promising clinical results have been obtained with radiolabeled antibodies in lymphoma patients.
The higher uptake by lymphomas of 67Gallium (6'Ga) compared with monoclonal antibodies makes selective
radiotherapy by the widely available 67Ga appealing. However, the gamma radiation of 67Ga uised in
scintigraphy is considered to be almost non-toxic to lymphoma cells. However, in addition to photon radiation
67Ga emits low energy Auger electrons and 80-90 keV conversion electrons which could be cytotoxic. The
objective of the present study was the assessment of radiotoxicity of 67Ga on a lymphoid cell line: U937.
Proliferation (MTT-assay) and clonogenic capacity (CFU-assay) were measured after 3 and 6 days incubation
with 10, 20 and 40 LCi ml-' 67Ga.
Growth inhibition was 36% after 3 days incubation and 63% after 6 days incubation with 40 jICi 67Ga ml-'.
Clonogenic capacity was reduced by 51% after 3 days and 72% after 6 days incubation with 40 jiCi ml- 67Ga.
A survival curve showed an initial shoulder and became steeper beyond 200-250 pCi cell-' (low linear energy
transfer type). Iso-effect doses of 67Ga and 9'Yttrium (9Y) were determined. The iso-effect dose of 40 jICi
67Ga ml-' (cumulative dose of conversion electrons 306 cGy) was 2.5 jiCi 90Y ml-' (cumulative dose 494 cGy)
and the iso-effect dose of 80 pCi 67Ga ml- was 5.0 pCi 90Y/ml. The main cytotoxic effect of 67Ga seems to be
induced by the 80 keV conversion electrons. We conclude that the conversion electrons of 67Ga have a
cytotoxic effect on U937 cells and that in our experiments a 16-fold higher piCi-dose of 67Ga than of 9Y was
needed for the same cytotoxic effect. We believe that 67Ga holds promise for therapeutic use.
67Gallium (67Ga) is being used in diagnostic imaging to detect
sites of infection and is well known for its ability to
accumulate in many malignant tissues, especially lymphomas
(Watson et al., 1973; Nelson et al., 1972).
To a large extent this accumulation resembles the antibody
mediated uptake of 9'Yttrium and '3'Iodine in lymphomas in
the clinical studies of Vriesendorp et al. (1989, 1991), Press et
al. (1989) and Goldenberg et al. (1991). In these studies very
promising tumour reductive effects were obtained in lym-
phoma patients. Selective radiotherapy by the widely
available 67Ga is an appealing idea. However, the gamma
radiation of 67Ga used in scintigraphy is considered to be
almost non-toxic to lymphoma cells because only very little
energy is absorbed by the tissue (low Linear Energy Trans-
fer). Besides gamma radiation, however, 67Ga emits very low
energy 0.1-8.0 keV Auger electrons and low energy
80-90 keV conversion electrons and these electrons could
very well be cytotoxic to lymphoma cells (high Linear Energy
Transfer). On the other hand, Auger electrons have to be
localised inside each cell, probably in association with the
DNA to exert a cytotoxic effect.
In the present study we investigated the cytotoxic effect of
67Ga on a lymphoma cell line: U937. Iso-effect doses of 67Ga
and 9Yttrium (90Y) were sought to relate the cytotoxic effect
of 67Ga to the well known cytotoxic effect of 'Y.
Materials and methods
Radionuclides
67Gallium was obtained from Mallinckrodt Diagnostics Hol-
land B.V. as 67-Ga-chloride. 67Ga-citrate was prepared as
follows: 0.1 ml GaC13 (0.7-0.8 N HCI, specific activity:
50 mCi ml-) was added to 4.0 ml Na-citrate stock solution.
This stock solution was prepared as follows: 1.17 ml Na-
citrate (Trisodium-citrate, C6H5Na307.2H2O), 150 gr- 1') was
added to 15 ml 0.1 N NaOH and the mixture diluted to
100 ml with NaCl 0.9% and the pH adjusted to 7.0. For
sterilisation a micropore filter 0.2 jLm (Schleicher & Schuell)
was used.
9Yttrium colloidal citrate was obtained from CIS bio
international, ORIS industry S.A., Gif-sur-Yvette Cedex,
France. Specific activity: 4.3 mCi ml '.
For purposes of convenience, activities are given as mCi,
jiCi and pCi (1 mCi = 37 MBq).
Cells and culture conditions
U937 cells, originally derived from a patient with a diffuse
histiocytic lymphoma, were purchased from ATCC (Rock-
ville, Maryland, USA), and have been maintained in RPMI-
1640-L-Glutamine (Gibco-Europe, Breda, NL) with 10%
heat-inactivated foetal calf serum (FCS; Gibco, Bio Cult,
Irvine, Scotland). Cells were incubated with 67Ga during a
culture with an initial cell concentration of 0.5 x 106 ml-'
(total volume 5 ml) in 50 cm3 culture flasks (Nunc 1-63371,
Life Technology, Breda, NL) in a medium consisting of
RPMI-1640 supplemented with 1% heat-inactivated human
serum, 25 mM hepes buffer, 100 U ml-' penicillin, 100 jig
ml-' streptomycin containing either 10jiCiml-1, 20jiCi
ml-', 40 jiCi ml- ' of 67Ga citrate or sodium-citrate in a con-
centration corresponding with the highest concentration of
67Ga used (40 jiCi ml-') or no addition. On day 3 after initial
seeding aliquots were taken for cell counting, 67Ga uptake
study, MTT- and CFU-assays. The remaining cells were
centrifuged at 100g for 10min and resuspended in the
original medium with or without 67Ga. From day 3 to 6 the
cells were allowed further proliferation and incubation with
67Ga. On day 6 again 67Ga uptake studies, MTT and CFU-
assays were performed. In separate experiments the effects of
incubation with 401jCiml1' and 80jiCiml-' of 67Ga were
compared with 1.25 jiCi ml-', 2.5 iCi ml-', 5.0 iLCiml-1, 10
jiCiml-' and 20jiCiml-' 90Yttrium colloidal citrate. MTT-
and CFU-assays were performed as described. Cells were
counted by a flow cytometric technique on an Al 134 Cell
counter (Analys instruments) and checked for viability by
trypan blue dye exclusion. Initially viability was always
>95%. Cells were cultured at 37°C, 5% C02, 90% relative
humidity. Percentage inhibition of proliferation in cell
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counts, colony forming units and MTT optical densities was
calculated as follows: 100- (mean value after incubation with
67Ga/mean value control * 100%). Cytospins (350 r.p.m.,
10min, Cytospin 2, Shandon) were prepared for May Giem-
sa Grunwald staining. Cell cultures were regularly checked to
be negative for mycoplasma using a gen probe kit (Lab Serv
Benelux).
Cellular uptake of67Ga
Aliquots of 0.3 ml were taken from the cell suspensions
incubated with 67Ga. Cells were washed three times with cold
phosphate buffered saline (PBS, pH = 7.4) and subsequent
supernatants and cell pellets were counted with a gamma
scintillation counter (compugamma 1282, Wallac). 67Ga up-
take was determined as follows: %67Ga uptake= bound
c.p.m. + bound + free c.p.m. Cellular 67Ga content was deter-
mined as follows: initial 67Ga concentration * elapsed ti *
%67Ga uptake + cell number/ml. In separate experiments the
dependency of the 67Ga uptake on transferrin concentrations
was studied. In these experiments 67Ga uptake of U937 cells
(0.5 x 106 ml-) was measured using 1 fLCi 67Ga added to
RPMI-1640-L-glycine supplemented with different concentra-
tions of human apotransferrin (Sigma: T 1147, 98% iron
free, St. Louis, USA) and in RPMI-1640-L-glutamine sup-
plemented with 1% human serum or 15% foetal calf serum.
After 6 h incubation at 37°C, uptake of 67Ga was measured
as described above.
MTT-Assay
Inhibition of proliferation after incubation with 67Ga was
measured in a colorimetric MTT-assay as previously des-
cribed (Twentyman et al., 1989; Price & McMillan, 1990).
Cells incubated with or without 67Ga were washed and
resuspended in fresh RPMI 1640-1% human serum medium
and 200 JLl aliquots containing 3,000 vital cells were plated in
triplicate in 96 wells round-bottomed micro-culture plates
(Greiner 650180, Alphen a/d Rijn, NL). After 1, 4 and 7 days
of culture 20iLl MTT (3-[4,5 dimethylthiazol-2-yl]-2,5
diphenyl tetrazolium bromide [Sigma MTT M2128; 5 mgml-'])
was added to each well. Plates were incubated in the dark for
4 h at 37°C after which the plates were centrifuged at 275g
for 5 min. The supernatants were aspirated and the formazan
crystals dissolved in 175jil DMSO/glycine buffer (150ftl
DMSO, Sigma D 8779 ACS + 25 ItI glycine buffer (0.1 M
glycine, pH 10.5)). Complete solubilisation was achieved by
vigorously shaking on a microplate shaker for 15 min. The
absorbance (Optical Density: OD) was measured on an eight
channel spectrophotometer (Titertek Multiscan MCC 340,
Flow Laboratory) at a wavelength of 540 nm.
Colonyforming unit (CFU-C) assay
Fifty ;LI of a 1.0 x 106ml-' vital cell suspension was sus-
pended in 2.5 ml placenta conditioned medium (manufac-
tured at the Central Laboratory of the Netherlands Red
Cross, Amsterdam, NL), 0.9% methylcellulose (final concen-
tration) and 723 lal Iscove's modified Dulbecco's medium
(supplemented with L-glutamine, without NaHCO3 dissolved
in 500 ml H20; Gibco 074022200A, Breda, NL). After mix-
ing, 2201l of the suspension was plated (double) in a 24
wells culture plate (Costar, 3424 Mark II, One Alewile
center, Cambridge, UK). The surrounding wells were filled
with sterile water to prevent dehydration. After 7 days of
culture clusters (>8, <40 cells) and colonies (>40 cells)
were counted with an inverted microscope. Total CFU count
is defined as the sum of clusters and colonies. Plating
efficiency for the control cells was 40-50%.
Absorbed dose calculations
The absorbed dose in the cells originating from P-particles,
gamma rays, X-rays and internal conversion electrons was
calculated with the assumption that the radioactivity is dis-
tributed homogeneously, according to the MIRD (Medical
Internal Radiation Dose Committee) Loevinger & Berman
(1976). For the P-particles, as well as for the internal conversion
electrons, an absorbed dose fraction of 1.0 in the cell culture was
assumed. The absorbed dose fractions for the gamma rays and
X-rays were estimated by a Monte Carlo stimulation (100,000
events). For the energy of the Auger electrons in the emission
spectrum of 67Ga, a complete, uniform absorption in the cell
(diameter of 12.5j.m) was assumed.
The residence time in the 5 ml culture flask was estimated
on the basis of physical decay and a constant uptake of 1%
per 500,000 cells ml1. Residence times in the wells were
based on the assumption that the uptake of 1% per 500,000
cells ml-' remains inside the cells (for 67Ga), or that the
radio-activity cannot be separated from the cells (for 90Y). To
calculate the residence time in the cells for 67Ga, a mono-
exponential curve was used which describes the concentration
decrease because of cell division.
Statistics
Two sample analysis was performed with the Stat-Graphics
2.6 statistical computer program. A 95% confidence interval
was computed for the hypothesis: difference in means = 0. If
the hypothesis was not rejected at a = 0.05 the difference was
considered statistically significant. Error bars shown in fig-
ures indicate the standard error of the mean (s.e.m.).
Results
6'Ga-Gallium uptake
67Ga uptake was found to be rather constant (1.0-1.5%) at a
medium transferrin concentration ranging from 0 to 1 pg
ml-' (Figure 1). A slightly higher uptake (not significant) was
observed for a transferrin concentration of 1O0ugml-'.
Transferrin concentrations over 100pgml-' caused a sharp
decline in 67Ga uptake. 67Ga uptake in 1% human serum
supplemented serum (1.74% ± 0.54) was higher than in 15%
foetal calf serum supplemented medium (0.76% ± 0.18) (Fig-
ure 1).
In the experiments measuring 67Ga cytotoxicity, U937 cells
were incubated in a 1% human serum supplemented medium.
67Ga uptake was measured in each experiment after 3 and 6
days incubation. Mean 67Ga uptake values after 3 days were
1.9%, 1.69% and 1.9% for 40jCi ml-', 20 tCi ml-' and
1OlCi ml-' concentration respectively. The mean 67Ga up-
take after 6 days incubation measured 0.92%, 1.9% and
1.3% for the same concentrations. Cells incubated with
40 LCi 67Gaml-' had a statistically significant lower 67Ga
cellular uptake after 6 vs 3 days.
Proliferation after exposure to 6'Gallium
Cell counts were performed after 3 and 6 days ofculture with
67Ga (Table I). No significant difference was found between
control cells and cells incubated with non-radioactive sod-
ium-citrate.
After 3 days incubation with 67Ga a proliferation inhibition
of 7.4%, 7.4% and 18% was seen for 10fiCiml-', 20pCi ml-' and 40pCi ml-' concentration of 67Ga respectively. Cell
counts after 6 days incubation with 67Ga showed a reduction
compared with control cells of 7%, 21% and 22% for 10, 20
and 40ItCi ml 67Ga respectively. The reduction in cell num-
ber compared with control cells after incubation with 40jtCi
67Ga ml-' was statistically significant after both incubation
periods. A concentration of 20 tLCi 67Ga ml-' showed a
statistically significant effect compared with control cells only
after 6 days incubation with 67Ga.
Viability tended to be slightly lower in cultures incubated
with 20;iCiml' and 40 tCi ml' of 67Ga (Table I).GALLIUM-67 RADIOTOXICITY 695
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Figure 1 Percentage cellular "7Ga uptake by U937 cells depending on medium transferrin concentration (j.gml-'). In the same
experiments the cellular 67Ga was measured in a medium supplemented with 15% foetal calf serum and a medium with 1% human
serum. The observed 6'Ga uptake in the serum supplemented media are shown in the curve. (Mean ± s.e.m.; n = 3).
Table I Proliferation U937 cells after incubation with Gallium-67
3 Days Cell counts Viability MTT-optical density
67Ga 106Ml-I % day= 7
Control 1.45 (1.2-1.9) 91% 1.052 (0.453-1.56)
Citrate 1.45 (1.2-2.1) 91% 1.003 (0.404-1.41)
1 liCi 1.3 (1.17-1.7) 90% 0.76 (0.434-0.97)
20gLCi 1.4 (1.17-1.6) 90% 0.736 (0.424-0.91)
40ILCi 1.2* (0.8-1.6) 89% 0.583* (0.371-0.99)
6 Days
67Ga
Control 1.2 (0.7-1.4) 92% 1.052 (0.556-2.62)
Citrate 1.1 (0.6-1.5) 91% 1.125 (0.275-2.36)
10lCi 1.14 (0.7-1.3) 89% 0.579 (0.343-0.78)
20 iCi 0.92* (0.7-1.2) 89% 0.564 (0.354-0.76)
40ItCi 0.96* (0.4-1.2) 83% 0.53* (0.160-0.97)
Proliferation of U937 cells after 3 and 6 days of incubation with different
concentrations of 67Gallium was measured with cell counts and MTT-optical density
after 7 days of microtiter culture. Socium citrate in a concentration equal to the
40 LCi 67Ga ml-l concentration was used as extra control. Median values are shown
of 11 experiments. Numbers in parentheses indicate range. Statistically significant
differences compared with control cells are indicated with an asterisk (*).
MTT-assay
After 3 and 6 days of incubation with 67Ga cells were washed
and replated in a microplate culture to assess the residual
growth capacity. MTT measurements were made after 1, 4
and 7 days of microplate subculture. The optical densities
show a clear growth inhibition by 67Ga (Table I and Figure
2a and b). Cells incubated with 67Ga were still able to grow
but seem to proliferate more slowly. Figure 3a and b shows
the proliferation profile in a representative experiment. Fig-
ure 2a and b shows the relative inhibition of 67Ga incubated
cells vs the control cells in each experiment. No statistically
significant difference was observed between control cells and
citrate incubated cells. Proliferation was reduced, after 3 days
incubation with 10 lOCi ml' and 20fiCiml' of 67Ga, with
4% and 20% respectively (MTT-culture: day 7). This
difference was not statistically different from control cells.
After 6 days incubation with lOLCi ml- and 201tCi ml-'
67Ga the observed reduction of proliferation was 12% for
both concentrations (MTT-culture: day 7) (no statistically
significant difference from control cells). Incubation with
40pCi 67Ga ml-' for 3 days resulted in a growth inhibition
of 23% (day 4) and 36% (day 7) (significantly different from
control cells). Incubation with 40IACi 67Ga ml' for 6 days
resulted in an even more pronounced inhibition: 51% (day 4)
and 63% (day 7) (significantly different from control cells).
CFU-assay
Colony forming units (CFU's) assays were performed of the
control cells and the 3 and 6 days 67Ga incubated cultures. In
comparison with the control cells the CFU counts after 3
days incubation with 40 LCi 67Ga ml' were as follows: 51%
of clusters, 46% of colonies and 49% of total CFU's (Figure
4a). After 6 days incubation with 40iLCi 67Gaml' 30% of
clusters, 27% of colonies and 28% of total CFU's were
found (Figure 4b). The reduction of CFU's compared with
control cells after incubation with 40pCi 67Ga ml-1 for 3 or
6 days periods was statistically significant. No statistically
significant differences in CFU counts were found after
incubation with 1I0 iCi ml- or 20 ICi mI' 67Ga.
The mean 67Ga content (pCi cell-') was estimated using
the 67Ga-uptake results and this 67Ga content in each experi-
ment was related to the total CFU's of the same experiment.
Figure 5 shows a dose-effect curve with a bend around
200-250pCi cell-'.696 A.R. JONKHOFF et al.
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Figure 2 Residual growth capacity after incubation with 67Ga was measured in a MTT assay. Data represent the relative optical
densities vs control values at 1, 4 and 7 days of subculture after 3 days incubation with 67Ga a, and after 6 days incubation with
67Ga b. Sodium citrate: (-*-), lOpCi 67Gaml-': (--O--), 20OLpCi 67Ga ml-: (--A--), 40OgCi 67Gaml-': (V...).
* = P<0.05. (Median ± s.e.m.; n = 11).
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Figure 3 Optical densities (MTT-assay) are shown of a representative experiment. Control: (- + -), sodium citrate: (-0-),
I0OgCi 67Gaml-': (-0 -), 20gCi 67Gaml-t: (--A- ), 4OiLCi 67Gaml -: (...V...). Optical densities were measured 1, 4 and 7 days
after 3 days incubation with 67Ga a, and after 6 days incubation with 67Ga b.
6"Gallium compared with 9 Yttrium-colloid
In three experiments the cytotoxicity of 67Ga and 9Y on
U937 cells were compared. Uptake studies showed that 99%
of 9Yttrium (9Y)-colloid was cell associated or could not be
separated by centrifugation. However, the high energy of the
P-particles (max 2.3 deV) of 9Y implicate that the radiation
dose is not influence by the location of the radionuclide in
this in vitro model.
In the MTT-assay a concentration of > 5 1tCi 9Y ml-
seemed necessary to prevent proliferation (data not shown).
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Figure 5 Surviving fraction of U937 cells measured by the CFU-assay related to the intracellular content of67Ga (pCi cell- ). The
curve shows a typical low LET profile with a broad initial shoulder.
The inhibitory effect of 80 laCi 67Ga ml in the MTT-assay
was comparable with a concentration of 90Y between 2.5 yCi
ml- and 5.0ILCi ml- (data not shown).
The CFU-assay after 3 days incubation with 67Ga showed
a reduction of 38% and 60% for 40,Ci 67Ga ml' and
80 jCi 67Ga ml-' dose respectively. The 40jsCi ml-' concen-
tration of 67Ga was comparable with 2.5fiCi 9Yml1 (38%
vs 38% reduction in CFU's) and 801ACiml' of 67-Ga was
comparable with an 9Y concentration between 2.5 and
5.0JLCimli' (60% vs 38%-83% reduction in CFU's) (Fig-
ure 6a}. After 6 days (Figure 6b) 40gsCi 67Ga ml-' equalled
2.5 yCi 90Yml' (64% vs 70% reduction in CFU's) and
80 LCi 67Gaml-' equalled 5.0 iCi 90Yml'l (97% vs 98%
reduction in CFU's). In these experiments further culturing
after 3 days of the 20IsCi 9Y ml-' incubated cells was
prevented by low vital cell counts.
Morphology
Control cells as well as 67Ga incubated U937 cells showed
enhanced granularity, probably a culture artefact.
After 3 and 6 days cells, that had been incubated with
citrate, or with l0I Ciml-', 20 sCiml-', 4O0sCiml-i and
80lnCiml- of 67Ga showed no clear differences compared
with control cells. The only apparent difference after 6 days
incubation with 80iLCi 67Gaml-' seemed to be a higher
number ofcells with two or more nuclei, and somewhat more
apoptotic cells, but otherwise the cells looked quite normal698 A.R. JONKHOFF et al.
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Figure 6 Colony forming units (CFU) counts after incubation with 401sCi ml-I and 80iLCi ml-' of 67Ga and various concentra-
tions of 9Y (1.25-20 lACi ml-'). CFU counts are shown after an incubation period of 3 days a, and after 6 days b. * = P<0.05.
(Median ± s.e.m.; n = 3).
with the same number of mitotic figures. In contrast, even
after incubation with 1.25pCi 9Y ml1 for 3 days cells
showed already signs of necrosis with smearing of nuclear
material. Incubation for 3 days with 2.5pCiml-', 5.0pCi
ml', lOtLCiml-' and 20OgCiml' of 9'Y resulted in 50%,
80%, 90% and 100% necrotic cells respectively.
Absorbed dose calculations
Table II shows the comparative dosimetry for 67Ga (40tcCi
ml-') and 9'Y (2.5fiCi ml-'). Initial dose rates (cGy h-') and
cumulative dose (cGy, in parentheses) are given.
Discussion
The present study shows an inhibitory effect of 67Ga on
proliferation of the lymphocytic cell line: U937. Six days
incubation with 40fsCi 67Ga ml-' resulted in an inhibition of
22% in cell number and 63% in MTT optical density signal.
The CFU-assay showed a 72% reduction in clonogenic
capacity of U937 cells after incubation with 40 jcCi 67Ga mlh '
for 6 days. After incubation with 80 ftCi 67Ga ml-' an even
greater reduction in CFU's of 97% was observed. The
inhibitory effect on proliferation (MTT-assay) does not
necessarily indicate cell killing and could also be explained by
mitotic delay (Cole et al., 1980). However, the reduced
clonogenic capacity after incubation with 67Ga clearly shows
a cytotoxic effect on clonogenic cells, probably the most
important cells to be killed. A dose-effect relation of 67Ga
could be established with a broad initial 'shoulder' fitting a
low Linear Energy Transfer (LET) type of cytotoxicity (Kas-
sis et al., 1988). The bending of the curve was around the
200-250 pCi cell-' and the cellular activity required to
reduce the clonogenic capacity to 37% (D37) was 350 pCi
cell '. This D37 is substantially higher than those of DNA-
associated auger emitters as [12511] or [77Br]-BrdU with a high
Table II Comparative dosimetry of 6"Ga and 90Y
67Ga (Augers 67Ga (Augers
90Y excluded) included)
2.5tsCiml-' 40 tLCiml- 40gACiml-'
5 ml culture 5.0 (247) 2.9 (153) 20.6 (792)
(3 days)
5 ml culture 5.0 (494) 2.9 (306) 20.6 (1584)
(6 days)
Small wells 0.034 (2.63) 0.0004 (0-04) 6.4 (220)
(MTT, 7 days)
Large wells 0.015 (1.12) 0.0002 (0.016) 6.3 (315)
(CFU, 7 days)
Initial dose rates (cGy h-') of 40gACi 67Ga ml-' and 2.5fCi
90Y ml-' during different experimental conditions were calculated
according to the MIRD, (Loevinger, 1976). The absorbed dose
fractions for the gamma rays and X-rays were estimated by a Monte
Carlo simulation (100,000 events). Absorbed dose calculations of
6'Ga were calculated with and without Auger electrons. Numbers in
parentheses indicate the cumulative dose (cGy), 1 JLCi = 0.037 MBq.
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LET type of cytotoxicity with a D37 of 0.13 pCi cell-' or
cytoplasmatic localised auger emitters with a low LET type
cytotoxicity as [75Se]-selenomethionine (D37= 3.9 pCi cell-')
(Kassis et al., 1988; 1989). A possible explanation for the
extremely broad shoulder could be that the cellular 67Ga
concentration, which induces a radiation dose dependent on
Auger electrons, underestimates the radiation dose that the
cells receive from the 67Ga in the medium (conversion elec-
trons). This is in accordance with our dosimetry results,
which indicate that the Auger electrons seem to add relatively
little to the cytotoxic effect (see below). On the other hand
Hofer et al. needed a high 67Ga dose to induce a minimal
cytotoxic effect of 67Ga on mice bearing peritoneal L 1210
leukaemia cells labelled with [251I]-IUDR (Hofer et al., 1975).
For a 50% cell-lethality 50 KeV cell-' h-' ['251]-IUDR was
needed, compared with 325 KeV cell-' h-' (10 cGy h-') for
[3H]-Thymidine and 2250 KeV cell-lh-1 (69 cGy h-') for
67Ga. In our experiments a cytotoxic effect of 67Ga was
already observed at an initial dose rate of 20cGyh-'. In
another study on 67Ga cytotoxicity, Martin et al. (1988)
studied the effects of a 67Ga-DNA-ligand as well as 67Ga-
citrate on isolated DNA and observed double-stranded DNA
breaks with both substrates, the ligand being more effective
than 67Ga-citrate.
In order to place the data in perspective we comparatively
assessed the cytotoxicity and dose effect relationships of
67Ga-citrate and 9Y-colloid. We selected this radionuclide
because its well known cytotoxicity in animal and human
studies (Vriezendorp et al., 1989, 1991; Bloomer et al., 1984)
and the comparable half-lifes of 67Ga (78 h) and 9Y (64 h).
We found that after a 6 days incubation period the cytotox-
icity of 40 iLCi 67Ga ml-' equalled 2.5 yCi 90Y ml-' (64% vs
70% reduction in CFU's) and 80 LCi 67Ga ml-' equalled
5.0ytCi 0Y ml-' (97% vs 98% reduction in CFU's). In our
experiments an about 16 times higher 67Ga pCi dose as 9Y
seems to induce the same cytotoxic effect. Whether a cyto-
toxic concentration of 67Ga can be reached in vivo should be
addressed in a clinical study. A 16 times higher 67Ga-dose
would mean that for a therapeutic effect 320-640 mCi 67Ga
is needed, as 20-40 mCi 90Y was required for a clinical effect
in the studies of Vriesendorp et al. However, the high uptake
of 67Ga in malignant tissues (0.01%-0.025% of the injected
dose per gram) after intravenous administration (Nelson,
1972) compared with radiolabelled antibodies (uptake gener-
ally <0.012% ID/g) (Press et al., 1989; Carrasquillo et al.,
1986; Bunn et al., 1984), suggests that in vivo possibly less
than 16 times the 9Y dose might be needed for the same
cytotoxic effect. An additional advantage, as compared with
monoclonal antibodies would be that 67Ga-citrate does not
induce immunological phenomena which might preclude
repeated treatments.
Surprisingly, cells incubated for 6 days with 80 lCi 67Ga
ml-' looked quite normal, as contrasted with cells incubated
with 9Y, showing necrosis. However, effects on clonogenic
capacity were very similar. These observations might indicate
either delayed cell death as reported by others (Shipley et al.,
1981) or a more pronounced effect of 67Ga on clonogenic
cells.
Differences in emission spectrum, only high energy p-
radiation (2.27 MeV) for 9'Y and gamma-radiation, Auger
electrons (0.1-8 keV) and conversion electrons (80-90 keV)
for 67Ga make a valid comparison difficult, although the
absorbed energy during the experimental conditions could be
estimated. Comparative dosimetry for iso-effect doses of67Ga
(40 .tCi ml-') and 9Y (2.5pCi ml-') after 6 days showed a
cumulative dose of 9Y of 494 cGy (an initial dose rate of
5.0cGy h-') and cumulative dose of 67Ga (Auger electrons
excluded) of 306 cGy (initial dose rate 2.9 cGy h-'). The
calculated dose of 67Ga with Augers included was much
higher (1584cGy). These data indicate that the Auger elec-
trons seems to add relatively little to the cytotoxic effect.
Most likely, the main cytotoxic effect of 67Ga can be attri-
buted to the 80 keV conversion electrons.
In conclusion our results show a substantial cytotoxic
effect of 67Ga on proliferation and clonogenic capacity of
human U937 cells. This cytotoxic effect is most probably
induced by 80 keV conversion electrons. We think further
research is worthwhile to explore the therapeutic potential of
this widely available isotope.
This study was supported by a grant of the Dutch Cancer Society
(IKA 91-07).
References
BLOOMER, W.D., MCLAUGHLIN, W.H., LAMBRECHT, R.M., AT-
CHER, R.W., MIRZADEH, S., MADARA, J.L., MILIUS, R.A., ZAL-
UTSKY, M.R., ADELSTEIN, S.J. & WOLF, A.P. (1984). 211-As
radiocolloid therapy: further observations and comparison with
radiocolloids of 32-P, 165-Dy, and 90-Y. Int. J. Radiat. Oncol.
Biol. Phys., 10, 341-348.
BUNN, P.A., CARRASQUILLO, J.A., KEENAN, A.M., SCHROFF, R.W.,
FOON, K.A., MING-HSU, S., GAZDAR, A.F., REYNOLDS, J.C.,
PERENTESIS, P. & LARSON, S.M. (1984). Imaging of T-cell lym-
phoma by radiolabeled monoclonal antibody. Lancer, 2, 1219-
1221.
CARRASQUILLO, J.A., BUNN, P.A., KEENAN, A.M., REYNOLDS, J.C.,
SCHROFF, R.W., FOON, K.A., MING-HSU, S., GAZDAR, A.F.,
MULSHINE, J.L., OLDHAM, R.K., PERENTESIS, P., HOROWITZ,
M., EDDY, J., JAMES, P. & LARSON, S.M. (1986). Radioim-
munodetection ofcutaneous T-cell lymphoma with 111-In-labeled
TIOI monoclonal antibody. N. Engl. J. Med., 315, 673-680.
COLE, A., MEYN, R.E., CHEN, R., CORRY, P.M. & HITTELMAN, W.
(1980). Mechanisms of cell injury. In: Radiat. Biol. Cancer Res.,
Meyn, R.E. & Withers, H.R. (eds), pp. 35-58, Raven Press: New
York.
GOLDENBERG, D.M., HOROWITZ, J.A., SHARKEY, R.M., HALL, T.C.,
MURTHY, S., GOLDENBERG, H., LEE, R.E., STEIN, R., SIEGEL,
J.A., IZON, D.O., BURGER, K., SWAYNE, L.C., BELISLE, E., HAN-
SEN, H.J. & PINSKY, C.M. (1991). Targeting, dosimetry, and
radioimmunotherapy of B-cell lymphomas with iodine-131-
labeled LL2 monoclonal antibody. J. Clin. Oncol., 9, 548-564.
HOFER, K.G., HARRIS, C.R. & SMITH, J.M. (1975). Radiotoxicity of
intracellular 67-Ga, 125-I and 3-H nuclear versus cytoplasmic
radiation effects in murine L-1210 leukemia. Int. J. Radiat. Biol.,
28, 225-241.
KASSIS, A.I., HOWELL, R.W., SASTRY, K.S.R. & ADELSTEIN, S.J.
(1988). Positional effects of Auger decays in mammalian cells in
culture. In DNA Damage by Auger Emitters, Baverstock, K.F. &
Charlton, D.E. (eds), pp. 1- 13, Taylor & Francis Publ: Philadel-
phia, USA.
KASSIS, A.I., FAYAT, F., KINSEY, B.M., SASTRY, K.S.R. & ADEL-
STEIN, S.J. (1989). Radiotoxicity of an 125-I-labeled DNA inter-
calator in mammalian cells. Radiat. Res., 118, 283-294.
LOEVINGER, R. & BERMAN, M. (1976). A revised scheme for cal-
culating the absorbed dose from biologically distributed radio-
nuclides; MIRD pamphlet no 1 (revised). Society of Nuclear
Medicine, New York.
MARTIN, R.E., ALLEN, B.J., D'CUNHA, G., GIBBS, R., MURRAY, V. &
PARDEE, M. (1988). DNA damage by Auger emitters. In DNA
Damage by Auger Emitters, Baverstock, K.F. & Charlton, D.E.
(eds) pp. 63-64, Taylor & Francis Publ: Philadelphia, USA.
NELSON, B., HAYES, R.L., EDWARDS, C.L., KNISELEY, R.M. & AN-
DREWS, G.A. (1972). Distribution of gallium in human tissues,
after intravenous administration. J. Nucl. Med., 13, 92-100.
PRESS, O.W., EARY, J.F., BADGER, C.C., MARTIN, P.J., APPELBAUM,
F.R., LEVY, R., MILLER, R., BROWN, S., NELP, W.B., KROHN,
K.A., FISHER, D., DESANTES, K., PORTER, B., KIDD, P., THOMAS,
E.D. & BERNSTEIN, I.D. (1989). Treatment of refractory Non-
Hodgkin's Lymphoma with radiolabeled MB-1 (anti-CD37) anti-
body. J. Clin. Oncol., 7, 1027-1038.
PRICE, P. & MCMILLAN, T.J. (1990). Use of the tetrazolium assay in
measuring the response of human tumor cells to ionizing radia-
tion. Cancer Res., 50, 1392-1396.700 A.R. JONKHOFF et al.
SHIPLEY, W.V., JENNINGS, M., GERWICK, L.E. & LING, C.C. (1981).
Prolonged 'ultra' low dose rate irradiation: effects on chinese
hamster cell population growth, survival, and radiation sen-
sitivity. Radiat. Res., 85, 150-160.
TWENTYMAN, P.R., FOX, N.E. & REES, K.H. (1989). Chemosen-
sitivity testing of fresh leukemia cells using the MT' colorimetric
assay. Br. J. Haematol., 71, 19-24.
VRIESENDORP, H.M., HERPST, J.M., LEICHNER, P.K., KLEIN, J.L. &
ORDER, S.E. (1990). Polyclonal 90-Yttrium labeled antiferritin for
refractory Hodgkin's disase. Int. J. Radiat. Oncol. Biol. Phys., 17,
815-821.
VRIESENDORP, H.M., HERPST, J.M., GERMACK, M.A., KLEIN, J.L.
LEICHNER, P.K., LOUDENSLAGER, D.W. & ORDER, S.E. (1991).
Phase I-II studies of Yttrium-labelled antiferritin treatment for
end stage Hodgkin's disease, including radiation therapy onco-
logy group 87-01. J. Clin. Oncol., 9, 918-928.
WATSON, E.E., CLOUTIER, R.J. & GIBBS, W.D. (1973). Whole-body
retention of 67Ga-citrate. J. Nucl. Med., 14, 840-842.